Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Rare Hematology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rare Hematologymarket, defines the market attractiveness level of Rare Hematology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rare Hematology industry, describes the types of Rare Hematology market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rare Hematology market and the development prospects and opportunities of Rare Hematology industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rare Hematology market in Chapter 13.
By Player:
CSL Behring LLC
Amgen Inc
Celgene Corporation
Biogen Inc
PRA Health Sciences
Pfizer Inc
Novo Nordisk A/S
Shire plc
Alexion Pharmaceuticals, Inc
Bayer Healthcare AG
By Type:
Recombinant Factors
Plasma Derived Factors
By End-User:
Pediatric
Adult
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rare Hematology Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rare Hematology Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rare Hematology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rare Hematology Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rare Hematology Market Analysis and Outlook to 2022
-
7.1 Global Rare Hematology Consumption (2017-2022)
-
7.2 United States Rare Hematology Consumption (2017-2022)
-
7.3 Europe Rare Hematology Consumption (2017-2022)
-
7.4 China Rare Hematology Consumption (2017-2022)
-
7.5 Japan Rare Hematology Consumption (2017-2022)
-
7.6 India Rare Hematology Consumption (2017-2022)
-
7.7 South Korea Rare Hematology Consumption (2017-2022)
8 Region and Country-wise Rare Hematology Market Analysis and Outlook to 2028
-
8.1 Global Rare Hematology Consumption Forecast (2022-2028)
-
8.2 United States Rare Hematology Consumption Forecast (2022-2028)
-
8.3 Europe Rare Hematology Consumption Forecast (2022-2028)
-
8.4 China Rare Hematology Consumption Forecast (2022-2028)
-
8.5 Japan Rare Hematology Consumption Forecast (2022-2028)
-
8.6 India Rare Hematology Consumption Forecast (2022-2028)
-
8.7 South Korea Rare Hematology Consumption Forecast (2022-2028)
9 Global Rare Hematology Market Outlook by Types and Applications to 2022
-
9.1 Global Rare Hematology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Recombinant Factors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plasma Derived Factors Consumption and Growth Rate (2017-2022)
-
9.2 Global Rare Hematology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pediatric Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adult Consumption and Growth Rate (2017-2022)
10 Global Rare Hematology Market Outlook by Types and Applications to 2028
-
10.1 Global Rare Hematology Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Recombinant Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Plasma Derived Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rare Hematology Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)
11 Global Rare Hematology Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rare Hematology Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rare Hematology Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rare Hematology Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rare Hematology Market Competitive Analysis
-
14.1 CSL Behring LLC
-
14.1.1 CSL Behring LLC Company Details
-
14.1.2 CSL Behring LLC Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CSL Behring LLC Rare Hematology Product and Service
-
14.2 Amgen Inc
-
14.2.1 Amgen Inc Company Details
-
14.2.2 Amgen Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Inc Rare Hematology Product and Service
-
14.3 Celgene Corporation
-
14.3.1 Celgene Corporation Company Details
-
14.3.2 Celgene Corporation Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Corporation Rare Hematology Product and Service
-
14.4 Biogen Inc
-
14.4.1 Biogen Inc Company Details
-
14.4.2 Biogen Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Inc Rare Hematology Product and Service
-
14.5 PRA Health Sciences
-
14.5.1 PRA Health Sciences Company Details
-
14.5.2 PRA Health Sciences Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 PRA Health Sciences Rare Hematology Product and Service
-
14.6 Pfizer Inc
-
14.6.1 Pfizer Inc Company Details
-
14.6.2 Pfizer Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Inc Rare Hematology Product and Service
-
14.7 Novo Nordisk A/S
-
14.7.1 Novo Nordisk A/S Company Details
-
14.7.2 Novo Nordisk A/S Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk A/S Rare Hematology Product and Service
-
14.8 Shire plc
-
14.8.1 Shire plc Company Details
-
14.8.2 Shire plc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire plc Rare Hematology Product and Service
-
14.9 Alexion Pharmaceuticals, Inc
-
14.9.1 Alexion Pharmaceuticals, Inc Company Details
-
14.9.2 Alexion Pharmaceuticals, Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alexion Pharmaceuticals, Inc Rare Hematology Product and Service
-
14.10 Bayer Healthcare AG
-
14.10.1 Bayer Healthcare AG Company Details
-
14.10.2 Bayer Healthcare AG Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer Healthcare AG Rare Hematology Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rare Hematology
-
Figure Rare Hematology Picture
-
Table Global Rare Hematology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rare Hematology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rare Hematology Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rare Hematology Consumption by Country (2017-2022)
-
Figure United States Rare Hematology Consumption and Growth Rate (2017-2022)
-
Table Europe Rare Hematology Consumption and Growth Rate (2017-2022)
-
Figure China Rare Hematology Consumption and Growth Rate (2017-2022)
-
Figure Japan Rare Hematology Consumption and Growth Rate (2017-2022)
-
Figure India Rare Hematology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rare Hematology Consumption and Growth Rate (2017-2022)
-
Figure Global Rare Hematology Consumption Forecast by Country (2022-2028)
-
Figure United States Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rare Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma Derived Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plasma Derived Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rare Hematology Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rare Hematology Export by Region (Top 5 Countries) (2017-2028)
-
Table CSL Behring LLC (Foundation Year, Company Profile and etc.)
-
Table CSL Behring LLC Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring LLC Rare Hematology Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Rare Hematology Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Rare Hematology Product and Service
-
Table Biogen Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Inc Rare Hematology Product and Service
-
Table PRA Health Sciences (Foundation Year, Company Profile and etc.)
-
Table PRA Health Sciences Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table PRA Health Sciences Rare Hematology Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Rare Hematology Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Rare Hematology Product and Service
-
Table Shire plc (Foundation Year, Company Profile and etc.)
-
Table Shire plc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire plc Rare Hematology Product and Service
-
Table Alexion Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Alexion Pharmaceuticals, Inc Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals, Inc Rare Hematology Product and Service
-
Table Bayer Healthcare AG (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare AG Rare Hematology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare AG Rare Hematology Product and Service
-
